Santarus Inc. (SNTS) Reports First Quarter 2013 Financial Results  
5/7/2013 7:53:57 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Santarus, Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, today reported financial and operating results for the quarter ended March 31, 2013.

Key financial results for the 2013 first quarter include:

•Total revenues of $79.4 million grew 73% compared with total revenues of $45.9 million in the first quarter of 2012

Help employers find you! Check out all the jobs and post your resume.